| Year |
Citation |
Score |
| 2017 |
Elzayat EM, Abdel-Rahman AA, Ahmed SM, Alanazi FK, Habib WA, Abou-Auda HS, Sakr A. Formulation and pharmacokinetics of multi-layered matrix tablets: Biphasic delivery of diclofenac. Saudi Pharmaceutical Journal : Spj : the Official Publication of the Saudi Pharmaceutical Society. 25: 688-695. PMID 28725140 DOI: 10.1016/j.jsps.2016.10.004 |
0.349 |
|
| 2016 |
Elzayat EM, Abdel-Rahman AA, Ahmed SM, Alanazi FK, Habib WA, Sakr A. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC. Acta Poloniae Pharmaceutica. 73: 439-52. PMID 27180437 |
0.413 |
|
| 2013 |
Mostafa HF, Ibrahim MA, Sakr A. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables. Pharmaceutical Development and Technology. 18: 454-63. PMID 22881389 DOI: 10.3109/10837450.2012.710237 |
0.408 |
|
| 2013 |
Fayed MH, Mahrous GM, Ibrahim MA, Sakr A. Influence of Carbopol 71G-NF on the release of dextromethorphan hydrobromide from extended-release matrix tablets. Pharmaceutical Development and Technology. 18: 971-81. PMID 21639691 DOI: 10.3109/10837450.2011.586037 |
0.402 |
|
| 2011 |
Sakr W, Alanazi F, Sakr A. Effect of Kollidon® SR on the release of Albuterol Sulphate from matrix tablets. Saudi Pharmaceutical Journal : Spj : the Official Publication of the Saudi Pharmaceutical Society. 19: 19-27. PMID 24115901 DOI: 10.1016/J.Jsps.2010.11.002 |
0.475 |
|
| 2011 |
Mostafa HF, Ibrahim MA, Mahrous GM, Sakr A. Assessment of the pharmaceutical quality of marketed enteric coated pantoprazole sodium sesquihydrate products. Saudi Pharmaceutical Journal : Spj : the Official Publication of the Saudi Pharmaceutical Society. 19: 123-7. PMID 23960750 DOI: 10.1016/J.Jsps.2011.01.001 |
0.383 |
|
| 2005 |
Owens TS, Dansereau RJ, Sakr A. Development and evaluation of extended release bioadhesive sodium fluoride tablets. International Journal of Pharmaceutics. 288: 109-22. PMID 15607263 DOI: 10.1016/J.Ijpharm.2004.09.017 |
0.733 |
|
| 2005 |
Gao Z, Nahrup JS, Mark JE, Sakr A. Poly(dimethylsiloxane) coatings for controlled drug release. III. Drug release profiles and swelling properties of the free-standing films Journal of Applied Polymer Science. 96: 494-501. DOI: 10.1002/App.21469 |
0.499 |
|
| 2004 |
Schulze Nahrup J, Gao ZM, Mark JE, Sakr A. Poly(dimethylsiloxane) coatings for controlled drug release--polymer modifications. International Journal of Pharmaceutics. 270: 199-208. PMID 14726135 DOI: 10.1016/J.Ijpharm.2003.10.007 |
0.467 |
|
| 2004 |
Kannamkumarath SS, Wuilloud RG, Stalcup A, Caruso JA, Patel H, Sakr A. Determination of levothyroxine and its degradation products in pharmaceutical tablets by HPLC-UV-ICP-MS Journal of Analytical Atomic Spectrometry. 19: 107-113. DOI: 10.1039/B307970H |
0.501 |
|
| 2004 |
Gao Z, Nahrup JS, Mark JE, Sakr A. Poly(dimethylsiloxane) coatings for controlled drug release. II. Mechanism of the crosslinking reaction in emulsion Journal of Applied Polymer Science. 91: 2186-2194. DOI: 10.1002/App.13341 |
0.464 |
|
| 2003 |
Hamed E, Gerson MC, Millard RW, Sakr A. A study of the pharmacodynamic differences between immediate and extended release bumetanide formulations. International Journal of Pharmaceutics. 267: 129-40. PMID 14602391 DOI: 10.1016/J.Ijpharm.2003.08.007 |
0.688 |
|
| 2003 |
Hamed E, Sakr A. Effect of curing conditions and plasticizer level on the release of highly lipophilic drug from coated multiparticulate drug delivery system. Pharmaceutical Development and Technology. 8: 397-407. PMID 14601964 DOI: 10.1081/Pdt-120024693 |
0.719 |
|
| 2003 |
Patel H, Stalcup A, Dansereau R, Sakr A. The effect of excipients on the stability of levothyroxine sodium pentahydrate tablets. International Journal of Pharmaceutics. 264: 35-43. PMID 12972334 DOI: 10.1016/S0378-5173(03)00387-9 |
0.518 |
|
| 2003 |
AlKhatib HS, Sakr A. Optimization of methacrylic acid ester copolymers blends as controlled release coatings using response surface methodology. Pharmaceutical Development and Technology. 8: 87-96. PMID 12665201 DOI: 10.1081/Pdt-120017527 |
0.716 |
|
| 2003 |
Takka S, Sakr A, Goldberg A. Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets. Journal of Controlled Release : Official Journal of the Controlled Release Society. 88: 147-57. PMID 12586512 DOI: 10.1016/S0168-3659(02)00490-X |
0.456 |
|
| 2003 |
Gao Z, Schulze Nahrup J, Mark JE, Sakr A. Poly(dimethylsiloxane) coatings for controlled drug release. I. Preparation and characterization of pharmaceutically acceptable materials Journal of Applied Polymer Science. 90: 658-666. DOI: 10.1002/App.12700 |
0.404 |
|
| 2002 |
Kornchankul W, Hamed E, Parikh NH, Sakr A. Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer. Die Pharmazie. 57: 49-53. PMID 11836931 |
0.605 |
|
| 2001 |
Hamed E, Sakr A. Application of multiple response optimization technique to extended release formulations design. Journal of Controlled Release : Official Journal of the Controlled Release Society. 73: 329-38. PMID 11516509 DOI: 10.1016/S0168-3659(01)00356-X |
0.692 |
|
| 2001 |
Sakr A, Andheria M. A Comparative Multidose Pharmacokinetic Study of Buspirone Extended‐Release Tablets with a Reference Immediate‐Release Product The Journal of Clinical Pharmacology. 41: 886-894. PMID 11504277 DOI: 10.1177/00912700122010681 |
0.373 |
|
| 2001 |
Sakr A, Andheria M. Pharmacokinetics of Buspirone Extended‐Release Tablets: A Single‐Dose Study The Journal of Clinical Pharmacology. 41: 783-789. PMID 11452712 DOI: 10.1177/00912700122010582 |
0.43 |
|
| 2001 |
Takka S, Rajbhandari S, Sakr A. Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 52: 75-82. PMID 11438426 DOI: 10.1016/S0939-6411(01)00147-3 |
0.419 |
|
| 2001 |
Allinson JG, Dansereau RJ, Sakr A. The effects of packaging on the stability of a moisture sensitive compound. International Journal of Pharmaceutics. 221: 49-56. PMID 11397566 DOI: 10.1016/S0378-5173(01)00670-6 |
0.32 |
|
| 2000 |
Cammarn SR, Sakr A. Predicting dissolution via hydrodynamics: salicylic acid tablets in flow through cell dissolution. International Journal of Pharmaceutics. 201: 199-209. PMID 10878326 DOI: 10.1016/S0378-5173(00)00415-4 |
0.58 |
|
| 2000 |
Kartal M, Khedr A, Sakr A. Liquid chromatographic method for the analysis of buspirone HCl and its potential impurities Journal of Chromatographic Science. 38: 151-156. PMID 10766481 DOI: 10.1093/Chromsci/38.4.151 |
0.329 |
|
| 2000 |
Khedr A, Sakr A. Stability-indicating high-performance liquid chromatographic assay of buspirone HCl. Journal of Chromatographic Science. 37: 462-8. PMID 10615593 DOI: 10.1093/Chromsci/37.12.462 |
0.371 |
|
| 2000 |
Turkoglu M, Aydin I, Murray M, Sakr A. Modeling of a roller-compaction process using neural networks and genetic algorithms. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 48: 239-45. PMID 10612035 DOI: 10.1016/S0939-6411(99)00054-5 |
0.302 |
|
| 1995 |
Hutchings DE, Sakr A. Influence of pH and plasticizers on drug release from ethylcellulose pseudolatex coated pellets. Journal of Pharmaceutical Sciences. 83: 1386-90. PMID 7884655 DOI: 10.1002/Jps.2600831004 |
0.413 |
|
| 1994 |
Menon A, Ritschel WA, Sakr A. Development and evaluation of a monolithic floating dosage form for furosemide. Journal of Pharmaceutical Sciences. 83: 239-45. PMID 8169797 DOI: 10.1002/Jps.2600830225 |
0.469 |
|
| 1994 |
Hutchings D, Kuzmak B, Sakr A. Processing Considerations for an EC Latex Coating System: Influence of Curing Time and Temperature Pharmaceutical Research. 11: 1474-1478. PMID 7855055 DOI: 10.1023/A:1018960310144 |
0.404 |
|
| 1994 |
Turkoglu M, Ritschel WA, Sakr A. In vivo evaluation of fluidized-bed coated pellets International Journal of Pharmaceutics. 103: 115-118. DOI: 10.1016/0378-5173(94)90090-6 |
0.394 |
|
| 1993 |
Khattab I, Menon A, Sakr A. Effect of mode of incorporation of disintegrants on the characteristics of fluid-bed wet-granulated tablets Journal of Pharmacy and Pharmacology. 45: 687-691. PMID 7901364 DOI: 10.1111/J.2042-7158.1993.Tb07089.X |
0.308 |
|
| 1992 |
Turkoglu M, Sakr A. Mathematical modelling and optimization of a rotary fluidized-bed coating process International Journal of Pharmaceutics. 88: 75-87. DOI: 10.1016/0378-5173(92)90305-L |
0.414 |
|
| 1991 |
Kraus C, Shaaya A, Ulmer J, Hutchings D, Menon A, Sakr A, Ritschel WA. Pharmacokinetics and bioavailability of papaverine HCl following intravenous, peroral, rectal, vaginal, topical and buccal administration in beagle dogs. Biopharmaceutics & Drug Disposition. 12: 537-46. PMID 1932615 DOI: 10.1002/Bdd.2510120707 |
0.358 |
|
| 1990 |
Ruiz R, Sakr A, Sprockel OL. A Study on the Manufacture and in Vitro Dissolution of Terbutaline Sulfate Microcapsules and their Tablets Drug Development and Industrial Pharmacy. 16: 1829-1842. DOI: 10.3109/03639049009025790 |
0.474 |
|
| Show low-probability matches. |